101 related articles for article (PubMed ID: 9570296)
1. HIV-1 vaccine candidate evaluation in non-human primates.
Lu Y
Crit Rev Oncog; 1997; 8(2-3):273-91. PubMed ID: 9570296
[TBL] [Abstract][Full Text] [Related]
2. In vivo protective anti-HIV immune responses in non-human primates through DNA immunization.
Boyer JD; Wang B; Ugen KE; Agadjanyan M; Javadian A; Frost P; Dang K; Carrano RA; Ciccarelli R; Coney L; Williams WV; Weiner DB
J Med Primatol; 1996 Jun; 25(3):242-50. PubMed ID: 8892046
[TBL] [Abstract][Full Text] [Related]
3. Fine specificity of anti-V3 antibodies induced in chimpanzees by HIV candidate vaccines.
Coëffier E; Girard M; Barré-Sinoussi F; Meignier B; Muchmore E; Fultz PN; LeClerc C
AIDS Res Hum Retroviruses; 1998 Aug; 14(12):1023-34. PubMed ID: 9718117
[TBL] [Abstract][Full Text] [Related]
4. A critical analysis of the cynomolgus macaque, Macaca fascicularis, as a model to test HIV-1/SIV vaccine efficacy.
Antony JM; MacDonald KS
Vaccine; 2015 Jun; 33(27):3073-83. PubMed ID: 25510387
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a vaccinia-derived recombinant HIV-1 gp160 candidate vaccine and its immunogenicity in chimpanzees.
Barrett N; Eder G; Dorner F
Biotechnol Ther; 1991; 2(1-2):91-106. PubMed ID: 1845126
[TBL] [Abstract][Full Text] [Related]
6. Where are we now with vaccines against AIDS?
Schild GC; Stott EJ
BMJ; 1993 Apr; 306(6883):947-8. PubMed ID: 8490466
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the immune response to recombinant gp120 in humans and chimpanzees.
Berman PW; Eastman DJ; Wilkes DM; Nakamura GR; Gregory TJ; Schwartz D; Gorse G; Belshe R; Clements ML; Byrn RA
AIDS; 1994 May; 8(5):591-601. PubMed ID: 7520248
[TBL] [Abstract][Full Text] [Related]
8. Utility of SHIV for testing HIV-1 vaccine candidates in macaques.
Lu Y; Salvato MS; Pauza CD; Li J; Sodroski J; Manson K; Wyand M; Letvin N; Jenkins S; Touzjian N; Chutkowski C; Kushner N; LeFaile M; Payne LG; Roberts B
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jun; 12(2):99-106. PubMed ID: 8680896
[TBL] [Abstract][Full Text] [Related]
9. Multi-envelope HIV vaccine safety and immunogenicity in small animals and chimpanzees.
Lockey TD; Slobod KS; Caver TE; D'Costa S; Owens RJ; McClure HM; Compans RW; Hurwitz JL
Immunol Res; 2000; 21(1):7-21. PubMed ID: 10803879
[TBL] [Abstract][Full Text] [Related]
10. Correlates of protective immunity against HIV-1 infection in immunized chimpanzees.
Murthy KK; Cobb EK; Rouse SR; Lunceford SM; Johnson DE; Galvan AR
Immunol Lett; 1996 Jun; 51(1-2):121-4. PubMed ID: 8811355
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of recombinant adenovirus-human immunodeficiency virus vaccines in chimpanzees following intranasal administration.
Lubeck MD; Natuk RJ; Chengalvala M; Chanda PK; Murthy KK; Murthy S; Mizutani S; Lee SG; Wade MS; Bhat BM
AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1443-9. PubMed ID: 7888199
[TBL] [Abstract][Full Text] [Related]
12. Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.
Dis Markers; 1991; 9(1):51. PubMed ID: 1742945
[No Abstract] [Full Text] [Related]
13. Therapeutic immunization of HIV-infected chimpanzees using HIV-1 plasmid antigens and interleukin-12 expressing plasmids.
Boyer JD; Cohen AD; Ugen KE; Edgeworth RL; Bennett M; Shah A; Schumann K; Nath B; Javadian A; Bagarazzi ML; Kim J; Weiner DB
AIDS; 2000 Jul; 14(11):1515-22. PubMed ID: 10983638
[TBL] [Abstract][Full Text] [Related]
14. Animal models for HIV infection and AIDS: memorandum from a WHO meeting.
Bull World Health Organ; 1988; 66(5):561-74. PubMed ID: 2850118
[TBL] [Abstract][Full Text] [Related]
15. Macaca mulatta, fascicularis and nemestrina in AIDS vaccine development.
Baroncelli S; Negri DR; Michelini Z; Cara A
Expert Rev Vaccines; 2008 Nov; 7(9):1419-34. PubMed ID: 18980543
[TBL] [Abstract][Full Text] [Related]
16. Vaccine protection of chimpanzees against challenge with HIV-1-infected peripheral blood mononuclear cells.
Fultz PN; Nara P; Barre-Sinoussi F; Chaput A; Greenberg ML; Muchmore E; Kieny MP; Girard M
Science; 1992 Jun; 256(5064):1687-90. PubMed ID: 1609280
[TBL] [Abstract][Full Text] [Related]
17. An assessment of the role of chimpanzees in AIDS vaccine research.
Bailey J
Altern Lab Anim; 2008 Sep; 36(4):381-428. PubMed ID: 18826331
[TBL] [Abstract][Full Text] [Related]
18. Antibody-dependent cellular cytotoxicity against HIV-1 in sera of immunized chimpanzees.
Belo M; Yagello M; Girard M; Greenlee R; Deslandres A; Barré-Sinoussi F; Gluckman JC
AIDS; 1991 Feb; 5(2):169-76. PubMed ID: 2031689
[TBL] [Abstract][Full Text] [Related]
19. Gene-mutated HIV-1/SIV chimeric viruses as AIDS live attenuated vaccines for potential human use.
Hayami M; Igarashi T; Kuwata T; Ui M; Haga T; Ami Y; Shinohara K; Honda M
Leukemia; 1999 Apr; 13 Suppl 1():S42-7. PubMed ID: 10232364
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 envelope-elicited neutralizing antibody titres correlate with protection and virus load in chimpanzees.
Bruck C; Thiriart C; Fabry L; Francotte M; Pala P; Van Opstal O; Culp J; Rosenberg M; De Wilde M; Heidt P; Heeney J
Vaccine; 1994 Sep; 12(12):1141-8. PubMed ID: 7998425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
